“硬科技军团”领跑全国

Group 1 - Shenzhen's listed companies are experiencing a surge in "new quality productivity" focused on hard technology and future industries, with R&D investment nearly doubling during the 14th Five-Year Plan period, reaching 210.3 billion yuan in 2024, a 91.35% increase from 2020 [1] - In the first three quarters of 2025, disclosed R&D expenses totaled 156.33 billion yuan, marking a historical high with a year-on-year growth of 11.59%, significantly outpacing the national average [1] - Approximately 80% of newly listed companies are from the Sci-Tech Innovation Board and the Growth Enterprise Market, with a total of 216 companies, representing over half of A-share Shenzhen enterprises, leading among major cities in China [1] Group 2 - A notable "innovation matrix" has formed in Shenzhen, with companies like UBTECH Robotics, Youjia Innovation, and SUTENG Juchuang leading in future industry directions, showcasing Shenzhen's advantages in the new technological revolution and industrial transformation [2] - The "Robot Valley" in Nanshan, centered around companies like UBTECH and Huichuan Technology, has created an industrial ecosystem, with UBTECH's Walker S1 robot being utilized in factories of major companies like BYD and Geely [2] - Huichuan Technology, valued at nearly 200 billion yuan, has increased its R&D investment from 1.023 billion yuan to 3.147 billion yuan over the past five years, successfully developing key components for humanoid robots [2] Group 3 - Innovation is not limited to individual companies but is also evident in collaborative evolution across industries, exemplified by Shenzhen Hanno Medical's breakthrough in developing China's first ECMO system, set to enter the EU market in May 2025 [3] - Mindray Medical, a major shareholder of Hanno Medical, has played a crucial role in supporting its technological advancements, illustrating the model of larger companies fostering innovation in smaller firms within the industry chain [3]